rs61731662

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_001242896.3(DEPDC5):ā€‹c.3358A>Gā€‹(p.Met1120Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0218 in 1,576,322 control chromosomes in the GnomAD database, including 439 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.023 ( 40 hom., cov: 33)
Exomes š‘“: 0.022 ( 399 hom. )

Consequence

DEPDC5
NM_001242896.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.0570
Variant links:
Genes affected
DEPDC5 (HGNC:18423): (DEP domain containing 5, GATOR1 subcomplex subunit) This gene encodes a member of the IML1 family of proteins involved in G-protein signaling pathways. The mechanistic target of rapamycin complex 1 (mTORC1) pathway regulates cell growth by sensing the availability of nutrients. The protein encoded by this gene is a component of the GATOR1 (GAP activity toward Rags) complex which inhibits the amino acid-sensing branch of the mTORC1 pathway. Mutations in this gene are associated with autosomal dominant familial focal epilepsy with variable foci. A single nucleotide polymorphism in an intron of this gene has been associated with an increased risk of hepatocellular carcinoma in individuals with chronic hepatitis C virus infection. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), DEPDC5. . Gene score misZ 2.6501 (greater than the threshold 3.09). Trascript score misZ 3.7275 (greater than threshold 3.09). GenCC has associacion of gene with focal epilepsy, Brugada syndrome, epilepsy, familial focal, with variable foci 1, familial focal epilepsy with variable foci, autosomal dominant epilepsy with auditory features, autosomal dominant nocturnal frontal lobe epilepsy.
BP4
Computational evidence support a benign effect (MetaRNN=0.0023645163).
BP6
Variant 22-31870617-A-G is Benign according to our data. Variant chr22-31870617-A-G is described in ClinVar as [Benign]. Clinvar id is 257661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31870617-A-G is described in Lovd as [Benign]. Variant chr22-31870617-A-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0233 (3555/152288) while in subpopulation AFR AF= 0.0287 (1194/41556). AF 95% confidence interval is 0.0274. There are 40 homozygotes in gnomad4. There are 1786 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 40 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DEPDC5NM_001242896.3 linkuse as main transcriptc.3358A>G p.Met1120Val missense_variant 34/43 ENST00000651528.2 NP_001229825.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DEPDC5ENST00000651528.2 linkuse as main transcriptc.3358A>G p.Met1120Val missense_variant 34/43 NM_001242896.3 ENSP00000498382 P4O75140-10

Frequencies

GnomAD3 genomes
AF:
0.0232
AC:
3531
AN:
152170
Hom.:
38
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0283
Gnomad AMI
AF:
0.0197
Gnomad AMR
AF:
0.0219
Gnomad ASJ
AF:
0.00950
Gnomad EAS
AF:
0.00442
Gnomad SAS
AF:
0.0217
Gnomad FIN
AF:
0.0301
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0213
Gnomad OTH
AF:
0.0330
GnomAD3 exomes
AF:
0.0213
AC:
4638
AN:
217906
Hom.:
58
AF XY:
0.0218
AC XY:
2585
AN XY:
118700
show subpopulations
Gnomad AFR exome
AF:
0.0279
Gnomad AMR exome
AF:
0.0146
Gnomad ASJ exome
AF:
0.0126
Gnomad EAS exome
AF:
0.00450
Gnomad SAS exome
AF:
0.0272
Gnomad FIN exome
AF:
0.0293
Gnomad NFE exome
AF:
0.0221
Gnomad OTH exome
AF:
0.0251
GnomAD4 exome
AF:
0.0217
AC:
30883
AN:
1424034
Hom.:
399
Cov.:
31
AF XY:
0.0219
AC XY:
15495
AN XY:
707340
show subpopulations
Gnomad4 AFR exome
AF:
0.0286
Gnomad4 AMR exome
AF:
0.0155
Gnomad4 ASJ exome
AF:
0.0106
Gnomad4 EAS exome
AF:
0.00293
Gnomad4 SAS exome
AF:
0.0265
Gnomad4 FIN exome
AF:
0.0303
Gnomad4 NFE exome
AF:
0.0218
Gnomad4 OTH exome
AF:
0.0218
GnomAD4 genome
AF:
0.0233
AC:
3555
AN:
152288
Hom.:
40
Cov.:
33
AF XY:
0.0240
AC XY:
1786
AN XY:
74476
show subpopulations
Gnomad4 AFR
AF:
0.0287
Gnomad4 AMR
AF:
0.0219
Gnomad4 ASJ
AF:
0.00950
Gnomad4 EAS
AF:
0.00443
Gnomad4 SAS
AF:
0.0220
Gnomad4 FIN
AF:
0.0301
Gnomad4 NFE
AF:
0.0213
Gnomad4 OTH
AF:
0.0326
Alfa
AF:
0.0220
Hom.:
71
Bravo
AF:
0.0234
TwinsUK
AF:
0.0205
AC:
76
ALSPAC
AF:
0.0192
AC:
74
ESP6500AA
AF:
0.0227
AC:
87
ESP6500EA
AF:
0.0240
AC:
199
ExAC
AF:
0.0210
AC:
2544
Asia WGS
AF:
0.0170
AC:
59
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Benign, criteria provided, single submitterclinical testingGeneDxJul 19, 2019- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMay 04, 2018- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsApr 27, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Familial focal epilepsy with variable foci Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 30, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.049
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
0.023
DANN
Benign
0.27
DEOGEN2
Benign
0.0098
.;.;.;.;.;T;.;.;.;.;T;.;.;.;.
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.0041
N
LIST_S2
Benign
0.58
T;T;T;T;T;T;.;.;T;T;.;T;.;T;T
MetaRNN
Benign
0.0024
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.4
.;.;.;.;.;N;.;.;.;.;N;.;.;N;.
MutationTaster
Benign
1.0
N;N;N;N;N;N;N;N;N
PrimateAI
Benign
0.27
T
PROVEAN
Benign
0.18
N;.;.;.;.;.;N;.;.;.;N;.;.;N;.
REVEL
Benign
0.024
Sift
Benign
0.89
T;.;.;.;.;.;T;.;.;.;T;.;.;T;.
Sift4G
Benign
0.48
T;.;.;.;.;.;T;.;.;.;T;.;.;T;.
Polyphen
0.0
.;.;B;.;.;.;.;.;.;.;.;.;B;.;.
Vest4
0.049
MPC
0.40
ClinPred
0.0014
T
GERP RS
-3.2
Varity_R
0.081

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61731662; hg19: chr22-32266603; COSMIC: COSV56707734; COSMIC: COSV56707734; API